Patents by Inventor Vivien Mak

Vivien Mak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060198883
    Abstract: Compositions and methods for the treatment of anorectal disorders are provided in which certain combinations of NO donors, PDE inhibitors, superoxide (O2?) scavengers, ?-adrenergic agonists, cAMP-dependent protein kinase activators, ?1-adrenergic antagonists, L-type Ca2+ channel blockers, estrogens, ATP-sensitive K+ channel activators and smooth muscle relaxants are used.
    Type: Application
    Filed: February 16, 2006
    Publication date: September 7, 2006
    Applicant: Cellegy Pharmaceuticals, Inc.
    Inventors: Thomas Parks, Vivien Mak, Jung-Chung Lee, Charles Lee
  • Publication number: 20060030622
    Abstract: The present invention provides methods for treating a variety of urogenital disorders, such as, for example, vaginismus, dyspareunia, vulvodynia (including vulvar vestibulitis), interstitial cystitis, nonspecific urethriris (i.e., nonspecific pain and/or burning of the urinary tract) and sexual dysfunctions, such as, for example, female sexual arousal disorders and female sexual orgasmic disorders, using a variety of compounds, including, but not limited to, NO donors, calcium channel blockers, cholinergic modulators, ?-adrenergic receptor antagonists, ?-adrenergic receptor agonists, phosphodiesterase inhibitors, cAMP-dependent protein kinase activators (e.g.
    Type: Application
    Filed: September 26, 2005
    Publication date: February 9, 2006
    Applicant: Cellegy Pharmaceuticals, Inc.
    Inventors: Vivien Mak, Stephen Grayson
  • Patent number: 6627632
    Abstract: Compositions and methods for the treatment of anorectal disorders are provided in which certain combinations of NO donors, PDE inhibitors, superoxide (O2−) scavengers, &bgr;-adrenergic agonists, cAMP-dependent protein kinase activators, &agr;1-adrenergic antagonists, L-type Ca2+ channel blockers, estrogens, ATP-sensitive K+ channel activators and smooth muscle relaxants are used.
    Type: Grant
    Filed: July 30, 2001
    Date of Patent: September 30, 2003
    Assignee: Cellegy Pharmaceuticals, Inc.
    Inventors: Thomas P. Parks, Vivien Mak, Jung-Chung Lee, Charles Lee
  • Publication number: 20020187990
    Abstract: Compositions and methods for the treatment of anorectal disorders are provided in which certain combinations of NO donors, PDE inhibitors, superoxide (O2−) scavengers, &bgr;-adrenergic agonists, cAMP-dependent protein kinase activators, &agr;1-adrenergic antagonists, L-type Ca2+ channel blockers, estrogens, ATP-sensitive K+ channel activators and smooth muscle relaxants are used.
    Type: Application
    Filed: July 17, 2002
    Publication date: December 12, 2002
    Applicant: Cellegy Pharmaceuticals, Inc.
    Inventors: Thomas P. Parks, Vivien Mak, Jung-Chung Lee, Charles Lee
  • Publication number: 20020072522
    Abstract: Compositions and methods for the treatment of anorectal disorders are provided in which certain combinations of NO donors, PDE inhibitors, superoxide (O2−) scavengers, &bgr;-adrenergic agonists, cAMP-dependent protein kinase activators, &agr;1-adrenergic antagonists, L-type Ca2+ channel blockers, estrogens, ATP-sensitive K+ channel activators and smooth muscle relaxants are used.
    Type: Application
    Filed: July 30, 2001
    Publication date: June 13, 2002
    Inventors: Thomas P. Parks, Vivien Mak, Jung-Chung Lee, Charles Lee
  • Patent number: 6395736
    Abstract: Compositions and methods for the treatment of anorectal disorders are provided in which certain combinations of NO donors, PDE inhibitors, superoxide (O2−) scavengers, &bgr;-adrenergic agonists, cAMP-dependent protein kinase activators, &agr;1-adrenergic antagonists, L-type Ca2+ channel blockers, estrogens, ATP-sensitive K+ channel activators and smooth muscle relaxants are used.
    Type: Grant
    Filed: December 13, 1999
    Date of Patent: May 28, 2002
    Assignee: Cellegy Pharmaceuticals, Inc.
    Inventors: Thomas P. Parks, Vivien Mak, Jung-Chung Lee, Charles Lee
  • Patent number: 6391869
    Abstract: Compositions and methods for the treatment of anorectal disorders are provided in which certain combinations of NO donors, PDE inhibitors, superoxide (O2−) scavengers, &bgr;-adrenergic agonists, cAMP-dependent protein kinase activators, &agr;1-adrenergic antagonists, L-type Ca2+ channel blockers, estrogens, ATP-sensitive K+ channel activators and smooth muscle relaxants are used.
    Type: Grant
    Filed: June 14, 2000
    Date of Patent: May 21, 2002
    Assignee: Cellergy Pharmaceuticals, Inc.
    Inventors: Thomas P. Parks, Vivien Mak, Jung-Chung Lee, Charles Lee
  • Publication number: 20010012856
    Abstract: Compositions and methods for the treatment of anorectal disorders are provided in which certain combinations of NO donors, PDE inhibitors, superoxide (O2−) scavengers, &bgr;-adrenergic agonists, cAMP-dependent protein kinase activators, &agr;1-adrenergic antagonists, L-type Ca2+ channel blockers, estrogens, ATP-sensitive K+ channel activators and smooth muscle relaxants are used.
    Type: Application
    Filed: January 23, 2001
    Publication date: August 9, 2001
    Applicant: Cellegy Pharmaceuticals, Inc.
    Inventors: Thomas P. Parks, Vivien Mak, Jung-Chung Lee, Charles Lee